Clinical Trials Logo

LGMD2E clinical trials

View clinical trials related to LGMD2E.

Filter by:
  • None
  • Page 1

NCT ID: NCT05989620 Recruiting - LGMD2I Clinical Trials

Long-Term Development of Muscular Dystrophy Outcome Assessments

GRASP-01-005
Start date: October 18, 2023
Phase:
Study type: Observational

This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).

NCT ID: NCT04509609 Completed - LGMD2E Clinical Trials

Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E

NeuroLGMD2E
Start date: June 1, 2020
Phase:
Study type: Observational

A retrospective observational study that will enable us to collect retrospective data from the clinical records of LGMD 2E patients in order to highlight any possible correlation between: - clinical variables and patient age, - clinical variables and other clinical variables, - clinical variables and clinical outcomes. The study will help to define the natural history of this rare disease and to ameliorate the management of these patients.